FOX
Bearish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. 1 purchase disclosure year to date, a thin reading
- Financial indicators Supports a bullish reading. Current ratio 3.17 · operating margin 24%
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. Weekly bias is flat
VENTE TOTALE: 149 934 titres (~10 274 977,02 $ US)
- Insiders
- MURDOCH LACHLAN K
- Total bought
-
—
Avg buy (VWAP, 90d window) $68.53 vs last close $56.54 (-17.5%)
- Total sold
-
$10,274,977
Avg sell (VWAP, 90d window) $68.53 vs last close $56.54 (-17.5%)
- Last activity
- 2026-09-15
- Liquidity
- Liquid $72,970,945/day · 20d vol
- Last synced
-
2026-09-25 21:10:26
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-15 | MURDOCH LACHLAN K | Sell | 149,934 | $68.53 | $10,274,977 | Form 4 |
| 2026-09-15 | MURDOCH LACHLAN K | Buy | 149,934 | $68.53 | $10,274,977 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-09-21
Despite a solid liquidity foundation (current ratio 3.17, liquidity score 85), FOX's weak and deteriorating fundamentals — compressed margins, a 94-day CCC, and negative PEG — significantly undermine its investment…
The first sentence of the analysis written for FOX on 2026-09-21 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 49.4% | 33.1% | 100.0% | 100.0% | 100.0% | |
| Ebit Margin | 15.3% | 21.3% | 17.9% | 14.0% | 14.8% | |
| Ebitda Margin | 17.7% | 23.6% | 20.7% | 16.7% | 17.4% | |
| Operating Profit Margin | 24.5% | 19.8% | 17.7% | 18.5% | 18.4% | |
| Pretax Profit Margin | 13.3% | 18.8% | 15.1% | 11.6% | 12.1% | |
| Continuous Operations Profit Margin | 10.1% | 14.1% | 11.1% | 8.4% | 8.8% | |
| Net Profit Margin | 9.8% | 13.9% | 10.7% | 8.3% | 8.6% | |
| Bottom Line Profit Margin | 9.8% | 13.9% | 10.7% | 8.3% | 8.6% | |
| Current Ratio | 3.169 | 2.910 | 2.541 | 1.929 | 3.607 | |
| Quick Ratio | 2.987 | 2.760 | 2.329 | 1.784 | 3.262 | |
| Solvency Ratio | 0.196 | 0.244 | 0.173 | 0.147 | 0.148 | |
| Cash Ratio | 1.577 | 1.847 | 1.463 | 1.135 | 2.265 | |
| Price To Earnings Ratio | 11.798 | 10.388 | 10.127 | 13.687 | 14.076 | |
| Price To Earnings Growth Ratio | -0.586 | 0.178 | 0.291 | 1.313 | -0.339 | |
| Forward Price To Earnings Growth Ratio | -0.586 | 0.178 | 0.291 | 1.313 | -0.339 | |
| Price To Earnings Diluted Ratio | 12.010 | 10.515 | 10.160 | 13.687 | 14.076 | |
| Price To Earnings Diluted Growth Ratio | -0.584 | 0.185 | 0.296 | 1.313 | -0.339 | |
| Price To Book Ratio | 1.708 | 1.990 | 1.419 | 1.632 | 1.493 | |
| Price To Sales Ratio | 1.160 | 1.460 | 1.087 | 1.135 | 1.211 | |
| Price To Free Cash Flow Ratio | 13.529 | 7.952 | 10.167 | 11.735 | 10.735 | |
| Price To Operating Cash Flow Ratio | 10.081 | 7.160 | 8.261 | 9.408 | 8.986 | |
| Debt To Assets Ratio | 0.337 | 0.322 | 0.371 | 0.375 | 0.348 | |
| Debt To Equity Ratio | 0.651 | 0.624 | 0.761 | 0.791 | 0.681 | |
| Debt To Capital Ratio | 0.394 | 0.384 | 0.432 | 0.442 | 0.405 | |
| Long Term Debt To Capital Ratio | 0.362 | 0.356 | 0.381 | 0.365 | 0.389 | |
| Financial Leverage Ratio | 1.933 | 1.939 | 2.051 | 2.107 | 1.957 | |
| Working Capital Turnover Ratio | 3.026 | 3.234 | 3.476 | 3.147 | 2.382 | |
| Operating Cash Flow Ratio | 0.739 | 1.147 | 0.623 | 0.478 | 0.821 | |
| Operating Cash Flow Sales Ratio | 0.115 | 0.204 | 0.132 | 0.121 | 0.135 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.745 | 0.900 | 0.812 | 0.802 | 0.837 | |
| Debt Service Coverage Ratio | 7.664 | 7.645 | 2.339 | 1.260 | 5.233 | |
| Interest Coverage Ratio | 12.938 | 8.012 | 6.119 | 7.920 | 6.828 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 3.072 | 1.441 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.260 | 0.445 | 0.226 | 0.219 | 0.244 | |
| Capital Expenditure Coverage Ratio | 3.924 | 10.042 | 5.333 | 5.042 | 6.137 | |
| Dividend Paid And Capex Coverage Ratio | 2.497 | 5.467 | 2.939 | 2.744 | 3.068 | |
| Dividend Payout Ratio | 0.170 | 0.122 | 0.187 | 0.241 | 0.255 | |
| Enterprise Value Multiple | 7.654 | 6.733 | 6.568 | 8.361 | 7.990 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 49.4% | ▲16.3% | ▼-27.1% |
| Ebit Margin | 15.3% | ▼-5.9% | ▼-1.3% |
| Ebitda Margin | 17.7% | ▼-5.9% | ▼-1.5% |
| Operating Profit Margin | 24.5% | ▲4.7% | ▲4.7% |
| Pretax Profit Margin | 13.3% | ▼-5.5% | ▼-0.9% |
| Continuous Operations Profit Margin | 10.1% | ▼-4.0% | ▼-0.4% |
| Net Profit Margin | 9.8% | ▼-4.0% | ▼-0.4% |
| Bottom Line Profit Margin | 9.8% | ▼-4.0% | ▼-0.4% |
| Current Ratio | 3.170 | ▲0.260 | ▲0.338 |
| Quick Ratio | 2.987 | ▲0.226 | ▲0.362 |
| Solvency Ratio | 0.196 | ▼-0.048 | ▲0.015 |
| Cash Ratio | 1.577 | ▼-0.270 | ▼-0.081 |
| Price To Earnings Ratio | 11.799 | ▲1.410 | ▼-0.217 |
| Price To Earnings Growth Ratio | -0.586 | ▼-0.765 | ▼-0.758 |
| Forward Price To Earnings Growth Ratio | -0.586 | ▼-0.765 | ▼-0.758 |
| Price To Earnings Diluted Ratio | 12.010 | ▲1.495 | ▼-0.079 |
| Price To Earnings Diluted Growth Ratio | -0.584 | ▼-0.769 | ▼-0.758 |
| Price To Book Ratio | 1.708 | ▼-0.282 | ▲0.060 |
| Price To Sales Ratio | 1.160 | ▼-0.301 | ▼-0.051 |
| Price To Free Cash Flow Ratio | 13.529 | ▲5.576 | ▲2.705 |
| Price To Operating Cash Flow Ratio | 10.081 | ▲2.921 | ▲1.302 |
| Debt To Assets Ratio | 0.337 | ▲0.015 | ▼-0.014 |
| Debt To Equity Ratio | 0.651 | ▲0.027 | ▼-0.051 |
| Debt To Capital Ratio | 0.394 | ▲0.010 | ▼-0.017 |
| Long Term Debt To Capital Ratio | 0.362 | ▲0.007 | ▼-0.008 |
| Financial Leverage Ratio | 1.933 | ▼-0.006 | ▼-0.064 |
| Working Capital Turnover Ratio | 3.026 | ▼-0.207 | ▼-0.027 |
| Operating Cash Flow Ratio | 0.739 | ▼-0.409 | ▼-0.023 |
| Operating Cash Flow Sales Ratio | 0.115 | ▼-0.089 | ▼-0.026 |
| Free Cash Flow Operating Cash Flow Ratio | 0.745 | ▼-0.155 | ▼-0.074 |
| Debt Service Coverage Ratio | 7.664 | ▲0.018 | ▲2.836 |
| Interest Coverage Ratio | 12.938 | ▲4.926 | ▲4.575 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | ▼-0.903 |
| Operating Cash Flow Coverage Ratio | 0.260 | ▼-0.185 | ▼-0.019 |
| Capital Expenditure Coverage Ratio | 3.924 | ▼-6.118 | ▼-2.171 |
| Dividend Paid And Capex Coverage Ratio | 2.497 | ▼-2.970 | ▼-0.846 |
| Dividend Payout Ratio | 0.170 | ▲0.048 | ▼-0.025 |
| Enterprise Value Multiple | 7.654 | ▲0.921 | ▲0.193 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $19.86B | $23.80B | $15.20B | $16.93B | $16.93B | |
| Enterprise value | $23.22B | $25.92B | $19.03B | $20.87B | $19.45B | |
| EV / Sales | 1.36x | 1.59x | 1.36x | 1.40x | 1.39x | |
| EV / Op. cash flow | 11.79x | 7.80x | 10.34x | 11.59x | 10.32x | |
| EV / Free cash flow | 15.82x | 8.66x | 12.73x | 14.46x | 12.33x | |
| EV / EBITDA | 7.65x | 6.73x | 6.57x | 8.36x | 7.99x | |
| Net debt / EBITDA | 1.11x | 0.55x | 1.32x | 1.58x | 1.03x | |
| Current ratio | 3.17x | 2.91x | 2.54x | 1.93x | 3.61x | |
| Income quality | 1.14x | 1.45x | 1.18x | 1.44x | 1.53x | |
| Graham number | $50 | $54 | $40 | $32 | $31 | |
| Graham net-net | -$9 | -$7 | -$9 | -$9 | -$6 | |
| Tax burden | 74.0% | 73.9% | 71.3% | 71.4% | 71.1% | |
| Interest burden | 86.8% | 88.4% | 83.9% | 83.3% | 81.8% | |
| Working capital | $5.79B | $5.53B | $4.55B | $3.49B | $5.99B | |
| Invested capital | $14.14B | $13.85B | $13.73B | $12.79B | $14.86B | |
| Return on assets | 7.5% | 9.8% | 6.8% | 5.7% | 5.4% | |
| Operating ROA | 18.4% | 14.3% | 11.3% | 12.5% | 11.4% | |
| Return on tangible assets | 10.6% | 13.6% | 9.8% | 8.1% | 7.8% | |
| Return on equity | 14.5% | 18.9% | 14.0% | 11.9% | 10.6% | |
| Return on invested capital | 16.0% | 11.9% | 9.3% | 10.3% | 9.4% | |
| Return on capital employed | 21.2% | 15.9% | 13.0% | 15.3% | 12.9% | |
| Earnings yield | 8.5% | 9.5% | 9.9% | 7.3% | 7.1% | |
| Free cash flow yield | 7.4% | 12.6% | 9.8% | 8.5% | 9.3% | |
| Capex / Op. cash flow | 25.5% | 10.0% | 18.8% | 19.8% | 16.3% | |
| Capex / Depreciation | 122.4% | 86.0% | 88.7% | 86.9% | 84.6% | |
| Capex / Sales | 2.9% | 2.0% | 2.5% | 2.4% | 2.2% | |
| SG&A / Sales | 13.8% | 13.3% | 14.5% | 13.7% | 13.7% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.8% | 0.8% | 0.6% | 0.5% | 0.7% | |
| Intangibles / Total assets | 29.0% | 28.5% | 30.0% | 30.4% | 30.3% | |
| Days sales outstanding | 74d | 55d | 62d | 53d | 56d | |
| Days payables outstanding | 0d | 0d | 0d | 0d | 0d | |
| Operating cycle | 94d | 70d | 62d | 53d | 56d | |
| Cash conversion cycle | 94d | 70d | 62d | 53d | 56d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-16.6%EV / Sales ▼-14.7%EV / EBITDA ▲+13.7%EV / Op. cash flow ▲+3.992Earnings yield ▼-0.010Graham number ▼-4.015
Profitability
Return on equity ▼-0.044Return on assets ▼-0.023Return on invested capital ▲+0.041Return on capital employed ▲+0.052Operating ROA ▲+0.041Income quality ▼-0.309Tax burden +0.000
Efficiency
Days sales outstanding ▲+18.281Days payables outstanding n/aOperating cycle ▲+24.318Cash conversion cycle ▲+24.318Capex / Sales ▲+0.009R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.260Net debt / EBITDA ▲+0.559Working capital ▲+254000000.000Invested capital ▲+300000000.000Intangibles / Total assets ▲+0.005
Change over 5 years
Valuation
Market cap ▲+17.3%EV / Sales ▼-2.6%EV / EBITDA ▼-4.2%EV / Op. cash flow ▲+1.466Earnings yield ▲+0.014Graham number ▲+18.759
Profitability
Return on equity ▲+0.039Return on assets ▲+0.021Return on invested capital ▲+0.066Return on capital employed ▲+0.082Operating ROA ▲+0.069Income quality ▼-0.387Tax burden ▲+0.028
Efficiency
Days sales outstanding ▲+18.052Days payables outstanding n/aOperating cycle ▲+38.552Cash conversion cycle ▲+38.552Capex / Sales ▲+0.007R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.437Net debt / EBITDA ▲+0.074Working capital ▼-199000000.000Invested capital ▼-710000000.000Intangibles / Total assets ▼-0.013
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-06-16 | Gilbert Ray Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2026-03-13 | Gilbert Ray Cisneros | Purchase | $1,001 - $15,000 |
| 2019-11-01 | Dean Phillips | Sale (Partial) | $1,001 - $15,000 |
| 2019-10-28 | Dean Phillips | Sale (Partial) | $1,001 - $15,000 |
| 2019-03-20 | Dean Phillips | Sale (Full) | $15,001 - $50,000 |
Recent news
- 2026-09-18 Kaplan Fox Encourages Investors of Innventure, Inc. (INV) to Act Ahead of the Lead Plaintiff Deadline on October 27, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Innventure, Inc. ("Innventure" or the "Company") (NASDAQ: INV) on behalf of investors that purchased or otherwise acquired Innventure securities between November 17, 2025 and August 13, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Innventure and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Encourages EquipmentShare.Com Inc (EQPT) Investors to Take Immediate Action in the Securities Class Action Before September 21, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against EquipmentShare.Com Inc ("EquipmentShare" or the "Company") (NASDAQ: EQPT) on behalf of investors who purchased or otherwise acquired EquipmentShare common stock pursuant and/or traceable to the Company''s initial public offering on or around January 23, 2026 (the "IPO"), or between January 23, 2026 and June 23, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in EquipmentShare and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (BBNX) - Lead Plaintiff Deadline is November 3, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Advises Investors of Wise Group plc (WSE) to Contact the Firm Before the Deadline on September 29, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Wise Group plc ("Wise Group" or the "Company") (NASDAQ: WSE) on behalf of investors that purchased or otherwise acquired Wise Group securities between May 11, 2026 and July 23, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Wise Group and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Notifies AEVEX Corp. (AVEX) Investors of an Upcoming Lead Plaintiff Deadline on October 20, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AEVEX Corp. ("AEVEX Corp" or the "Company") (NYSE: AVEX) on behalf of investors that purchased or otherwise acquired AEVEX Corp Class A Common Stock pursuant and/or traceable to the Company''s initial public offering on or about April 17, 2026 ("IPO"), or between April 17, 2026 and June 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in AEVEX Corp and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Encourages Medline Inc. (MDLN) Investors to Contact the Firm Regarding a Securities Investigation New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Urges Blaize Holdings, Inc. (BZAI) Investors Seeking Recovery to Contact the Firm Before October 5, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Blaize Holdings, Inc. ("Blaize Holdings" or the "Company") (NASDAQ: BZAI) on behalf of investors that purchased or otherwise acquired Blaize Holdings securities between July 18, 2025 and April 28, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Blaize Holdings and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Datavault AI Inc. (DVLT) on October 5, 2026 New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Datavault AI Inc. ("Datavault" or the "Company") (NASDAQ: DVLT) on behalf of investors that purchased or otherwise acquired Datavault securities between September 4, 2024 and October 30, 2025 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Datavault and have suffered losses, you may CLICK HERE to contact us.
- 2026-09-18 Lachlan Murdoch Purchases 149,934 Shares of FOX (NASDAQ:FOX) Stock Fox Corporation (NASDAQ: FOX - Get Free Report) CEO Lachlan Murdoch bought 149,934 shares of the firm''s stock in a transaction that occurred on Tuesday, September 15th. The shares were purchased at an average cost of $68.53 per share, with a total value of $10,274,977.02. Following the purchase, the chief executive officer directly owned 1,401,713 shares
- 2026-09-17 Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Innventure, Inc. (INV) on October 27, 2026 New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Innventure, Inc. ("Innventure" or the "Company") (NASDAQ: INV) on behalf of investors that purchased or otherwise acquired Innventure securities between November 17, 2025 and August 13, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Innventure and have suffered losses, you may CLICK HERE to contact us.